Wellington Management Group LLP Reduces Stock Position in Acadia Healthcare Company, Inc. $ACHC

Wellington Management Group LLP cut its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 36.9% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,726,246 shares of the company's stock after selling 3,346,696 shares during the period. Wellington Management Group LLP owned about 6.15% of Acadia Healthcare worth $169,096,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. EverSource Wealth Advisors LLC increased its stake in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after acquiring an additional 497 shares during the last quarter. Wells Fargo & Company MN lifted its stake in shares of Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company's stock valued at $32,000 after purchasing an additional 1,510 shares during the last quarter. Allworth Financial LP purchased a new position in shares of Acadia Healthcare in the 2nd quarter worth approximately $45,000. Global Retirement Partners LLC bought a new position in shares of Acadia Healthcare during the 2nd quarter valued at approximately $68,000. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company's stock valued at $76,000 after buying an additional 5,203 shares during the period.

Analyst Ratings Changes

A number of research analysts have weighed in on ACHC shares. UBS Group boosted their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a research report on Thursday, July 9th. Guggenheim lifted their price target on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a "buy" rating in a research note on Thursday, July 30th. Royal Bank Of Canada upped their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an "outperform" rating in a report on Monday, May 4th. KeyCorp raised their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 14th. Finally, Raymond James Financial upgraded Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 target price for the company in a research report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $29.85.

Acadia Healthcare Trading Down 3.5%

Shares of ACHC opened at $27.56 on Tuesday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. The firm has a market capitalization of $2.57 billion, a price-to-earnings ratio of -2.21, a PEG ratio of 9.20 and a beta of 0.64. The company has a 50-day moving average of $30.51 and a 200 day moving average of $26.25. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $35.83.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.03. The business had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company's revenue for the quarter was down .4% on a year-over-year basis. During the same quarter last year, the firm posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, research analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source